[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Page 21890]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08330]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-622]


Bulk Manufacturer of Controlled Substances Application: AMRI 
Rensselaer, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before June 19, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on March 9, 2020, AMRI Rensselaer, Inc., 33 Riverside 
Avenue, Rensselaer, New York 12144-2951, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substances:

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana...............................    7360  I
Tetrahydrocannabinols...................    7370  I
Amphetamine.............................    1100  II
Lisdexamfetamine........................    1205  II
Pentobarbital...........................    2270  II
ANPP (4-Anilino-N-phenethyl-4-              8333  II
 piperidine).
Codeine.................................    9050  II
Oxycodone...............................    9143  II
Hydromorphone...........................    9150  II
Hydrocodone.............................    9193  II
Meperidine..............................    9230  II
Morphine................................    9300  II
Fentanyl................................    9801  II
------------------------------------------------------------------------

    The company plans to manufacture the above controlled substances as 
bulk active pharmaceutical ingredients (APIs) for use in product 
development and for distribution to its customers. In reference to drug 
codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the company 
plans to bulk manufacture these drugs as synthetics. No other 
activities for these drug codes are authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08330 Filed 4-17-20; 8:45 am]
BILLING CODE 4410-09-P